Alcobra Ltd.(ADHD)- NASDAQ
Company Description
Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome.... More
Sector: Healthcare
Industry: Drug Related Products
Country: Israel